Wei He Selected Research

Renal Cell Carcinoma (Grawitz Tumor)

5/2024	Elevated histone deacetylase 10 expression promotes the progression of clear cell renal cell carcinoma by Notch-1-PTEN signaling axis.
8/2023	A novel technique for avoidance of sternotomy, diaphragmic incision and cardiopulmonary bypass during cavoatrial tumor thrombectomy for renal cell carcinoma with intraatrial tumor thrombus: a case series at a single center.
2/2023	Development of Prognostic Biomarkers by TMB-Guided WSI Analysis: A Two-Step Approach.
1/2023	Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma.
1/2023	Circulating succinate-modifying metabolites accurately classify and reflect the status of fumarate hydratase-deficient renal cell carcinoma.
12/2022	HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans.
1/2022	Identification of New m6A Methylation Modification Patterns and Tumor Microenvironment Infiltration Landscape that Predict Clinical Outcomes for Papillary Renal Cell Carcinoma Patients.
1/2021	A novel Apigenin derivative suppresses renal cell carcinoma via directly inhibiting wild-type and mutant MET.
1/2021	Comprehensive analysis of a new prognosis signature based on histone deacetylases in clear cell renal cell carcinoma.
1/2021	NUPR1 is a novel potential biomarker and confers resistance to sorafenib in clear cell renal cell carcinoma by increasing stemness and targeting the PTEN/AKT/mTOR pathway.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei He Research Topics

Disease

335	Neoplasms (Cancer) 04/2024 - 11/2002
66	Inflammation (Inflammations) 04/2024 - 01/2006
53	Infections 03/2024 - 07/2003
52	Breast Neoplasms (Breast Cancer) 03/2024 - 09/2005
50	Neoplasm Metastasis (Metastasis) 02/2024 - 06/2005
45	Osteonecrosis (Kienbock's Disease) 03/2024 - 10/2008
42	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 12/2007
38	Carcinoma (Carcinomatosis) 01/2023 - 11/2002
31	Pain (Aches) 09/2023 - 05/2006
29	Carcinogenesis 01/2024 - 01/2005
27	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023 - 11/2010
24	Prostatic Neoplasms (Prostate Cancer) 11/2023 - 10/2008
24	Wounds and Injuries (Trauma) 06/2023 - 07/2003
23	Hypoxia (Hypoxemia) 11/2023 - 01/2008
20	Renal Cell Carcinoma (Grawitz Tumor) 05/2024 - 05/2010
19	Osteoporosis 03/2024 - 05/2005
19	Dry Eye Syndromes (Dry Eye Syndrome) 02/2024 - 07/2020
19	Ischemia 01/2017 - 07/2003
18	Necrosis 07/2023 - 07/2003
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2022 - 08/2009
16	Leukemia 04/2024 - 12/2004
16	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 03/2010
16	Lung Neoplasms (Lung Cancer) 10/2022 - 08/2009
16	Body Weight (Weight, Body) 12/2021 - 07/2003
15	Hypertension (High Blood Pressure) 01/2024 - 12/2007
14	Lymphatic Metastasis 11/2023 - 06/2006
14	Esophageal Squamous Cell Carcinoma 11/2023 - 01/2009
14	Ischemic Stroke 04/2023 - 05/2013
13	Hemorrhage 03/2024 - 01/2015
13	Disease Progression 03/2024 - 10/2008
13	Colitis 10/2023 - 06/2006
13	Thrombosis (Thrombus) 08/2023 - 07/2003
13	Brain Ischemia (Cerebral Ischemia) 01/2023 - 11/2003
13	Type 2 Diabetes Mellitus (MODY) 11/2022 - 02/2007
13	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 06/2002
12	COVID-19 01/2024 - 08/2020
11	Acute Lung Injury 04/2024 - 01/2016
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 04/2013
11	Hyperalgesia 01/2023 - 03/2017
10	Sepsis (Septicemia) 03/2024 - 08/2017
10	Rheumatoid Arthritis 09/2023 - 05/2006
10	Reperfusion Injury 01/2023 - 01/2004
10	Fibrosis (Cirrhosis) 12/2022 - 12/2010
10	Obesity 05/2022 - 08/2015
9	Glioma (Gliomas) 03/2024 - 05/2012
9	Bone Resorption 03/2024 - 11/2015
9	Critical Illness (Critically Ill) 10/2023 - 01/2007
9	Stomach Neoplasms (Stomach Cancer) 10/2023 - 08/2009
9	Diabetes Mellitus 01/2019 - 09/2012

Drug/Important Bio-Agent (IBA)

127	Proteins (Proteins, Gene)FDA Link 03/2024 - 07/2003
50	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2005
40	CytokinesIBA 03/2024 - 02/2004
34	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2012
28	Messenger RNA (mRNA)IBA 03/2024 - 07/2003
28	SteroidsIBA 10/2023 - 07/2009
26	LigandsIBA 01/2023 - 01/2006
25	Therapeutic UsesIBA 03/2024 - 05/2006
25	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 06/2003
23	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 06/2008
23	AntigensIBA 11/2023 - 08/2002
22	Long Noncoding RNAIBA 03/2024 - 01/2016
21	LipidsIBA 02/2024 - 07/2009
20	VaccinesIBA 03/2024 - 12/2003
20	EnzymesIBA 02/2024 - 11/2003
18	Hormones (Hormone)IBA 03/2024 - 09/2004
17	Cisplatin (Platino)FDA LinkGeneric 10/2022 - 12/2008
16	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 10/2010
15	Insulin (Novolin)FDA Link 11/2023 - 08/2007
15	Interleukin-6 (Interleukin 6)IBA 12/2022 - 06/2002
14	LipopolysaccharidesIBA 12/2023 - 07/2003
14	Immunoglobulin G (IgG)IBA 04/2023 - 12/2003
13	Liposomes (Liposome)IBA 08/2023 - 07/2015
13	Paclitaxel (Taxol)FDA LinkGeneric 06/2023 - 08/2013
13	Small Interfering RNA (siRNA)IBA 12/2022 - 02/2009
12	AntibodiesIBA 10/2023 - 08/2002
12	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 02/2006
11	RNA (Ribonucleic Acid)IBA 12/2023 - 06/2007
11	salicylhydroxamic acid (SHAM)IBA 12/2023 - 10/2004
11	Estrogen ReceptorsIBA 10/2023 - 10/2016
11	InterleukinsIBA 03/2023 - 01/2006
11	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 06/2002
10	Circular RNAIBA 11/2023 - 01/2021
10	Blood Glucose (Blood Sugar)IBA 10/2023 - 05/2009
10	Retinaldehyde (Retinal)IBA 01/2022 - 01/2015
9	AntioxidantsIBA 04/2024 - 11/2003
9	FlavonoidsIBA 03/2024 - 07/2009
9	Peptides (Polypeptides)IBA 11/2023 - 05/2005
9	Folic Acid (Vitamin M)FDA LinkGeneric 04/2023 - 10/2008
9	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 04/2008
9	Everolimus FDA Link 01/2023 - 01/2016
9	Indicators and Reagents (Reagents)IBA 01/2022 - 12/2011
9	ErbB Receptors (EGF Receptor)IBA 01/2022 - 07/2015
9	Matrix Metalloproteinases (MMPs)IBA 06/2020 - 04/2013

Therapy/Procedure

170	Therapeutics 03/2024 - 02/2004
51	Drug Therapy (Chemotherapy) 01/2024 - 08/2009
30	Immunotherapy 05/2024 - 01/2005
21	Electroacupuncture 01/2023 - 12/2011
10	Radiotherapy 12/2023 - 08/2009
9	Aftercare (After-Treatment) 03/2024 - 05/2006
9	Hepatectomy 11/2023 - 07/2015